Sg Americas Securities, LLC Sana Biotechnology, Inc. Transaction History

Sg Americas Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$4.2 - $11.27 $53,999 - $144,898	-12,857 Reduced 52.76%	11,513 $115,000
Q4 2023 Jan 12, 2024	BUY	$2.8 - $4.55 $68,236 - $110,883	24,370 New	24,370 $99,000
Q2 2022 Jul 29, 2022	BUY	$4.12 - $9.35 $368,010 - $835,170	89,323 Added 311.0%	118,044 $759,000
Q1 2022 Apr 29, 2022	BUY	$5.24 - $15.58 $50,089 - $148,929	9,559 Added 49.89%	28,721 $237,000
Q4 2021 Feb 07, 2022	SELL	$15.18 - $23.15 $233,240 - $355,699	-15,365 Reduced 44.5%	19,162 $297,000
Q3 2021 Nov 01, 2021	BUY	$16.29 - $25.88 $314,429 - $499,535	19,302 Added 126.78%	34,527 $778,000
Q2 2021 Aug 12, 2021	BUY	$16.65 - $32.14 $143,939 - $277,850	8,645 Added 131.38%	15,225 $299,000
Q1 2021 May 13, 2021	BUY	$23.04 - $43.5 $151,603 - $286,230	6,580 New	6,580 $220,000

175

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $460M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.